BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
201 – 210 of 3087
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
(
- Contribution to journal › Article
-
Mark
Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations
(
- Contribution to journal › Article
-
Mark
How good are pathogenicity predictors in detecting benign variants?
(
- Contribution to journal › Article
-
Mark
The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast
(
- Contribution to journal › Article
-
Mark
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
(
- Contribution to journal › Article
-
Mark
The effect of the mTOR inhibitor rapamycin on glucoCEST signal in a preclinical model of glioblastoma
(
- Contribution to journal › Article
-
Mark
HER2 and p95HER2 differentially regulate miRNA expression in MCF-7 breast cancer cells and downregulate MYB proteins through miR-221/222 and miR-503
(
- Contribution to journal › Article
-
Mark
HMGA2 promotes long-term engraftment and myeloerythroid differentiation of human hematopoietic stem and progenitor cells
(
- Contribution to journal › Article
-
Mark
Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis
(
- Contribution to journal › Article
-
Mark
Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours : A Dose-Escalation Study
(
- Contribution to journal › Article